| Bid | 13.1 |
| Market Cap | 558.27M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -1.17 |
| PE Ratio (ttm) | -11.57 |
| Forward PE | n/a |
| Analyst | Buy |
| Ask | 14.07 |
| Volume | 342,049 |
| Avg. Volume (20D) | 595,514 |
| Open | 13.54 |
| Previous Close | 13.38 |
| Day's Range | 13.44 - 13.60 |
| 52-Week Range | 10.19 - 20.27 |
| Beta | undefined |
About VREX
Varex Imaging Corporation designs and manufactures X-ray imaging components. The company operates in two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components comprising X-ray tubes, digital detectors, high voltage connectors, image-processing software and workstations, 3D reconstruction and computer-aided diagnostic software, collimators, automatic exposure control devices, gene...
Analyst Forecast
According to 1 analyst ratings, the average rating for VREX stock is "Buy." The 12-month stock price forecast is $21, which is an increase of 55.10% from the latest price.
Next Earnings Release
Analysts project revenue of $192.65M, reflecting a 1.39% YoY growth and earnings per share of 0.02, making a -66.67% decrease YoY.
1 month ago · seekingalpha.com
Varex Imaging Corporation (VREX) Q4 2024 Earnings Call TranscriptVarex Imaging Corporation (NASDAQ:VREX ) Q4 2024 Earnings Conference Call November 19, 2024 5:00 PM ET Company Participants Christopher Belfiore - Director of Investor Relations Sunny Sanyal - Preside...
1 month ago · businesswire.com
Varex Announces Financial Results for Fourth Quarter and Fiscal Year 2024SALT LAKE CITY--(BUSINESS WIRE)--Varex Imaging Corporation (Nasdaq: VREX) today announced its unaudited financial results for the fourth quarter and fiscal year 2024. Q4 FY24 Summary Revenues of $206 ...
